Search website

If you cannot find, what you are looking for, try searching for it below or visit our FAQ-page.

Close

News & Events

The annual Tillotts BBQ in Rheinfelden, Switzerland

News

The annual Tillotts BBQ in Rheinfelden, Switzerland

A couple of weeks ago, Tillotts Pharma AG (“Tillotts”) hosted the annual Tillotts BBQ [...] Read more »
Tillotts Pharma AG featured in the Aargauer Zeitung

News

Tillotts Pharma AG featured in the Aargauer Zeitung

Tillotts Pharma AG (Tillotts) was featured in the Aargauer Zeitung on Thursday 24th of May[...] Read more »
Discrepancies between patients’ preferences and physicians’ preference perception for oral formulations: A real-life survey

Scientific publications

Discrepancies between patients’ preferences and physicians’ preference perception for oral formulations: A real-life survey

P. Marchi1, S. Timeus1, L. Mackenzie-Smith1, P. Le Calvé2, R. Young2 1Tillotts Pha[...] Read more »
Tillotts Pharma shows support for World IBD Day 2018

News

Tillotts Pharma shows support for World IBD Day 2018

World IBD Day takes place on 19 May each year and unites people from around the world in t[...] Read more »
Prof. Dr. Ulrich Mittmann and Dr. Roberto Gradnik step down as Tillotts Pharma AG board members

News

Prof. Dr. Ulrich Mittmann and Dr. Roberto Gradnik step down as Tillotts Pharma AG board members

As of 26 April 2018, Prof. Dr. Ulrich Mittmann and Dr. Roberto Gradnik have officially ste[...] Read more »
Tillotts Pharma AG signs POTELLIGENT<sup>®</sup> CHOK1SV<sup>TM</sup> Cell Line Technology Licensing Agreement with Lonza and BioWa

Press Release

Tillotts Pharma AG signs POTELLIGENT® CHOK1SVTM Cell Line Technology Licensing Agreement with Lonza and BioWa

• Tillotts Pharma AG will use the POTELLIGENT® CHOK1SV™ Cell Line, developed by Lonza[...] Read more »
1 2 3 13